MHC tetramer technology: Exploring T cell biology in health and disease
dc.contributor.author | Tiwari R. | |
dc.contributor.author | Singh V.K. | |
dc.contributor.author | Rajneesh | |
dc.contributor.author | Kumar A. | |
dc.contributor.author | Gautam V. | |
dc.contributor.author | Kumar R. | |
dc.date.accessioned | 2025-01-13T07:08:55Z | |
dc.date.available | 2025-01-13T07:08:55Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Major histocompatibility complex (MHC) tetramers stand as formidable tools within T cell biology, facilitating the exploration and comprehension of immune responses. These artificial molecules, comprising four bound MHC molecules, typically with a specified peptide and a fluorescent label, play a pivotal role in characterizing T cell subsets, monitoring clonal expansion, and unraveling T cell dynamics during responses to infections or immunotherapies. Beyond their applications in T cell biology, MHC tetramers prove valuable in investigating a spectrum of diseases such as infectious diseases, autoimmune disorders, and cancers. Their instrumental role extends to vaccine research and development. Notably, when appropriately configured, tetramers transcend T cell biology research and find utility in exploring natural killer T cells and contributing to specific T cell clonal deletions. � 2024 | |
dc.identifier.doi | 10.1016/bs.apcsb.2024.02.002 | |
dc.identifier.isbn | 978-044319350-7 | |
dc.identifier.issn | 18761623 | |
dc.identifier.uri | https://dl.bhu.ac.in/ir/handle/123456789/3459 | |
dc.language.iso | en | |
dc.publisher | Academic Press Inc. | |
dc.subject | Clonal expansion | |
dc.subject | Immune response | |
dc.subject | Major histocompatibility complex | |
dc.subject | Tetramer | |
dc.subject | Vaccine research | |
dc.title | MHC tetramer technology: Exploring T cell biology in health and disease | |
dc.type | Article | |
journal.title | Advances in Protein Chemistry and Structural Biology | |
journalvolume.identifier.volume | 140 |